Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Systems and methods for neuroprotective therapy of glaucoma

A glaucoma, eye technology, applied in the field of neuroprotective therapy of glaucoma, can solve problems such as reducing clear clinical efficacy

Active Publication Date: 2022-05-31
OJAI RETINAL TECH
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

While many therapies hold promise for neuroprotection, none to date have demonstrated definitive clinical efficacy beyond IOP reduction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Systems and methods for neuroprotective therapy of glaucoma
  • Systems and methods for neuroprotective therapy of glaucoma
  • Systems and methods for neuroprotective therapy of glaucoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0052] The present invention relates to a system and method for treating glaucoma. More specifically, the present invention relates to a

[0054] Referring to Figure 2, Figures 2A-2D are effective tables for various modes of retinal laser treatment for retinal vascular disease

[0055] Figure 2A illustrates the therapeutic efficacy of conventional argon laser retinal photocoagulation. due to laser-induced thermal retinal rupture

[0056] Referring to Figure 2B, conventional laser burns are shown with increased burn intensity. The burnt damaged tissue area 24 is visible

[0059] FIG. 3A illustrates the use of low intensity and low density lasers, such as micropulsed diode lasers, as used herein in accordance with the present invention.

[0064] Various parameters have been determined to achieve a "true" subthreshold or "low intensity" effective photocoagulation. These parameters include

[0067] The current power limitations of micropulsed diode lasers require relatively long ex...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provides neuroprotective therapy for glaucoma, including the generation of micropulsed laser beams with parameters and characteristics, including pulse length, power, and duty cycle, selected to produce a therapeutic effect without visually visible laser lesions or damage to the retina tissue damage. Laser beams are applied to the retinal tissue and / or foveal tissue of eyes with or at risk of glaucoma to produce therapeutic effects on the retinal tissue and / or foveal tissue exposed to the laser beam without destroying or permanently Damage retinal tissue and / or foveal tissue, and improve the function or condition of the optic nerve cells and / or retinal ganglion cells of the eye.

Description

Systems and methods for neuroprotective therapy of glaucoma technical field [0001] The present invention generally relates to the treatment of glaucoma. More specifically, the present invention relates to providing retinal Systems and methods of harmless subthreshold light therapy or light stimulation that improve the function or condition of the optic nerve of the eye and provide Neuroprotective therapy for glaucoma. Background technique [0002] The complications of diabetic retinopathy remain the leading cause of vision loss in people under the age of sixty. diabetes Macular edema is the most common legal cause of blindness in this patient population. Diabetic retinopathy and consequent diabetes The cause of macular edema, the increasing global incidence and prevalence of diabetes mellitus, is not only becoming a epidemics, but also in developing countries. Patients with type I (insulin-dependent) diabetes mellitus Within five years, diabetic retinopathy may...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61F9/008
CPCA61F9/008A61F2009/00863A61F2009/00891
Inventor J·K·卢特鲁勒B·W·L·马戈利斯D·B·昌
Owner OJAI RETINAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com